![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 2296-5262|39|1-2|25-32
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.39, Iss.1-2, 2016-0, pp. : 25-32
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ofatumumab for the treatment of chronic lymphocytic leukemia
Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New oral small molecules in the treatment of chronic lymphocytic leukemia
CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pathogenesis, Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Exciting Times
Oncology Research and Treatment, Vol. 39, Iss. 1-2, 2016-0 ,pp. :